January 13, 2021Open Access
New approaches to symptomatic treatments for Alzheimer’s disease
Key Points
Key points are not available for this paper at this time.
Abstract
Advances in developing new agents for cognitive and behavioral symptoms of AD combined with enhanced trial methods promise to address the unmet needs of patients with AD for improved cognition and amelioration of neuropsychiatric symptoms.